Tech Company Financing Transactions
Epigenomics AG Funding Round
3i Venture Capital, Abingworth and MPM Capital participated in a $22.5 million Series C venture round for Epigenomics AG. This VC investment round closed on 4/3/2003.
Transaction Overview
Company Name
Announced On
4/3/2003
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Series C
Investors
3i Venture Capital (Lead Investor) (Klaus Stckemann)
Abingworth (John Berriman)
MPM Capital (Michael Steinmetz)
Proceeds Purpose
Epigenomics will use the funds for the further development of its diagnostic products in cancer as well as its pharmacodiagnostic and research products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Geneststraße 5
Berlin, 10829
Germany
Berlin, 10829
Germany
Phone
Website
Email Address
Overview
Molecular diagnostics company designing cancer tests based on DNA methylation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Hamilton
Chief Scientific Officer
Jorge Garces
VP - Finance
Albert Weber
Browse more venture capital transactions:
Prev: 4/1/2003: E-Duction venture capital transaction
Next: 4/8/2003: Coherix venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs